- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03994718
Creative Arts II Study
Creative Arts Interventions for Improved Epilepsy Patient Quality of Life
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Qualifying patients admitted to Epilepsy Monitoring Unit will be approached for participation in the study. Patients who consent will be randomly assigned to work with one of three creative artists (visual artist, creative writer, or therapeutic musician. The assigned artist will provide 1 intervention while the patient is admitted and 4 follow-up interventions after discharge from the hospital. Follow-up sessions will be conducted remotely, either by phone or over the internet.
Subjects will be asked to complete study questionnaires before and after the first art intervention, and again after the last follow-up session. The study seeks to measure the impact of arts interventions on quality of life. Secondary objectives include the effects of the interventions on seizure frequency and EEG spike generation, as well as the impact of creative arts interventions on patients diagnosed with non-epileptic events during hospitalization.*
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New Hampshire
-
Lebanon, New Hampshire, United States, 03756
- Dartmouth-Hitchcock Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age > 18 years old
- Scheduled for admission to the Dartmouth-Hitchcock Medical Center Epilepsy Monitoring Unit for diagnostic Video/EEG monitoring
- Capable of giving informed consent.
- Able to follow instructions
Exclusion Criteria:
- Active psychiatric illness that would interfere with participation with the artist.
- Active general medical condition that would impair the participant's consciousness or ability to participate.
- Any other reason that, in the opinion of the investigator, would exclude the participant from successful participation in the study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Music
The musician will either offer music that can either be played for the participant or an instrument so they can experience playing themselves.
The duration of the intervention will be determined by participant interest and tolerance, but not to exceed 60 minutes.
The outpatient music intervention will consist of providing a recording of similar music for the participant to listen to for at least 30 minutes per week, along a with telephone call session with the music therapist.
|
The music therapist will work with subjects for up to 60 minutes each session.
|
Experimental: Visual art
The creative visual artist will assess interest in spending time using the materials provided.
Participants will be offered watercolor painting, drawing, or adult coloring.
There will be a guided activity based on their art making preference.
A standardized prompt will be utilized for both writing and visual art sessions.
The duration of the intervention will be determined by participant interest and tolerance, but not to exceed 60 minutes.
For remote follow-up sessions, participants will be supplied with a small art kit to use at home.
|
The visual artist will work with subjects for up to 60 minutes each session.
|
Experimental: Creative writing
The writer will ask the participant about their interests and experiences in writing or storytelling.
The following options are offered; introduction to journaling, storytelling or writing exercises with prompts to get started, interactive writing or storytelling activities.
For participants who are unable to write or prefer not to, the writer can scribe their words on a laptop and print them out.
The duration of the intervention will be determined by participant interest and tolerance, but not to exceed 60 minutes.
For follow-up sessions, participants will be supplied with a journal.
|
The creative writer will work with subjects for up to 60 minutes each session.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in participant Quality of Life (QOLIE-10) scores before and after the interventions.
Time Frame: Each participant will be assessed at baseline (Day 1) and after the inpatient intervention (approximately Day 3 - 21) and at baseline (Day 1) and after the follow-up remote interventions (approximately 8 weeks after discharge).
|
Change in quality of life will be calculated using the QOLIE-10 questionnaire responses.The QOLIE-10 includes 10 questions with a total score range of 10 - 51.
The score will be calculated by the sum of scores for all questions divided by the number of items answered.
Thus, if a patient skipped an item, it is not reflected in the total score.
A lower score indicates a higher quality of life, and a higher score indicates a lower quality of life.
|
Each participant will be assessed at baseline (Day 1) and after the inpatient intervention (approximately Day 3 - 21) and at baseline (Day 1) and after the follow-up remote interventions (approximately 8 weeks after discharge).
|
Change in participant Distress scores before and after the interventions.
Time Frame: Each participant will be assessed at baseline (Day 1) and after the inpatient intervention (approximately Day 3 - 21) and at baseline (Day 1) and after the follow-up remote interventions (approximately 8 weeks after discharge).
|
Change in distress will be calculated using the Distress scale.
The Distress scale asks patients to rate their distress on a scale from 0 - 10, with 0 meaning "no distress" and 10 meaning "extreme distress."
Lower scores indicate less distress.
|
Each participant will be assessed at baseline (Day 1) and after the inpatient intervention (approximately Day 3 - 21) and at baseline (Day 1) and after the follow-up remote interventions (approximately 8 weeks after discharge).
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in participant Patient Health Questionnaire (PHQ-9) scores before and after interventions.
Time Frame: Each participant will be assessed at baseline (Day 1) and after the inpatient intervention (approximately Day 3 - 21) and at baseline (Day 1) and after the follow-up remote interventions (approximately 8 weeks after discharge).
|
Change in health status will be calculated using the PHQ-9 questionnaire.
The PHQ-9 is a 9-item questionnaire with scores ranging from 0 to 27.
Lower scores indicate better health scores and higher scores represent worse health status.
Scores of 5, 10, 15, and 20 represent cutoffs for mild, moderate, moderately severe and severe depression, respectively.
|
Each participant will be assessed at baseline (Day 1) and after the inpatient intervention (approximately Day 3 - 21) and at baseline (Day 1) and after the follow-up remote interventions (approximately 8 weeks after discharge).
|
Change in participant Generalized Anxiety Disorder (GAD-7) scores before and after interventions.
Time Frame: Each participant will be assessed at baseline (Day 1) and after the inpatient intervention (approximately Day 3 - 21) and at baseline (Day 1) and after the follow-up remote interventions (approximately 8 weeks after discharge).
|
Change in anxiety level will be calculated using the GAD-7 questionnaire responses.
The GAD-7 is a 7-items questionnaire with scores ranging from 0 to 21. Scores of 5, 10, and 15 represent cut-offs for mild, moderate, and severe anxiety, respectively.
|
Each participant will be assessed at baseline (Day 1) and after the inpatient intervention (approximately Day 3 - 21) and at baseline (Day 1) and after the follow-up remote interventions (approximately 8 weeks after discharge).
|
Change in EEG spike frequency before, during, and after the intervention while participant is admitted to the DHMC epilepsy inpatient service.
Time Frame: Each participant will be assessed at baseline (Day 1) and after the inpatient intervention (approximately Day 3 - 21) and at baseline (Day 1) and after the follow-up remote interventions (approximately 8 weeks after discharge).
|
EEG spike frequency will be determined by automated spike detection software
|
Each participant will be assessed at baseline (Day 1) and after the inpatient intervention (approximately Day 3 - 21) and at baseline (Day 1) and after the follow-up remote interventions (approximately 8 weeks after discharge).
|
Change in seizure frequency from baseline to end of follow-up
Time Frame: Each participant will be assessed at baseline (Day 1) and after the inpatient intervention (approximately Day 3 - 21) and at baseline (Day 1) and after the follow-up remote interventions (approximately 8 weeks after discharge).
|
Comparison of seizure data at baseline and post-interventions based on patient report of baseline and seizure calendar reporting
|
Each participant will be assessed at baseline (Day 1) and after the inpatient intervention (approximately Day 3 - 21) and at baseline (Day 1) and after the follow-up remote interventions (approximately 8 weeks after discharge).
|
Qualitative analysis to identify themes in the creative writing and visual art subject matter.
Time Frame: After the inpatient intervention (approximately Day 3 - 21) and after each follow-up remote intervention (approximately 8 weeks after discharge).
|
Participants assigned to either the creative writer or to the visual artist will supply their creations for analysis.
The creative writing subject matter will be analyzed using N-Vivo software.
Visual art subject matter will be coded for thematic content manually.
|
After the inpatient intervention (approximately Day 3 - 21) and after each follow-up remote intervention (approximately 8 weeks after discharge).
|
Change in quality of life measures for participants ultimately diagnosed with non-epileptic seizures compared to those diagnosed with epileptic seizures.
Time Frame: Each participant will be assessed at baseline (Day 1) and after the inpatient intervention (approximately Day 3 - 21) and at baseline (Day 1) and after the follow-up remote interventions (approximately 8 weeks after discharge).
|
Change in quality of life for patients with non-epileptic seizures will be calculated using the QOLIE-10 questionnaire responses.The QOLIE-10 includes 10 questions.
The score is calculated by the sum of scores for all questions divided by the number of items answered.
Thus, if a patient skipped an item, it is not reflected in the total score.
A lower score indicates a higher quality of life, and a higher score indicates a lower quality of life.
|
Each participant will be assessed at baseline (Day 1) and after the inpatient intervention (approximately Day 3 - 21) and at baseline (Day 1) and after the follow-up remote interventions (approximately 8 weeks after discharge).
|
Collaborators and Investigators
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- D19124
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Epilepsy
-
NaviFUS CorporationTaipei Veterans General Hospital, TaiwanCompletedDrug Resistant Epilepsy | Epilepsy, Drug Resistant | Intractable Epilepsy | Refractory Epilepsy | Drug Refractory Epilepsy | Epilepsy, Drug Refractory | Epilepsy, Intractable | Medication Resistant EpilepsyTaiwan
-
Great Ormond Street Hospital for Children NHS Foundation...Active, not recruitingEpilepsies, Partial | Intractable Epilepsy | Focal Epilepsy | Refractory Epilepsy | Epilepsy Intractable | Epilepsy in Children | Epilepsy, FocalUnited Kingdom
-
University of British ColumbiaTerminatedJuvenile Myoclonic Epilepsy | Childhood Absence Epilepsy | Juvenile Absence EpilepsyCanada
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruiting
-
Neuroelectrics CorporationRecruitingEpilepsy | Seizures | Refractory Epilepsy | Epilepsy, Tonic-Clonic | Epilepsy in Children | Seizures, Focal | Focal SeizureSpain, United States, France, Belgium
-
Oslo University HospitalCompletedEpilepsy | Generalized Epilepsy | Focal EpilepsyNorway
-
UCB Pharma SACompletedEpilepsy, Tonic-clonicPoland, Sweden, Hungary, Czechia
-
UCB PharmaCompletedEpilepsy, Tonic-clonic
-
University Hospital, LilleUnknownFocal Epilepsy | Epilepsy IntractableFrance
-
Xuanwu Hospital, BeijingPeking University; Beijing Tiantan Hospital; Qilu Hospital of Shandong University and other collaboratorsNot yet recruitingEpilepsy, Drug ResistantChina
Clinical Trials on Music intervention
-
Toronto Metropolitan UniversityMitacsRecruitingStress, Psychological | Loneliness | Emotion Regulation | Well Being | Executive Functions | Functional AbilitiesCanada
-
Universidad Miguel Hernandez de ElcheCompletedCardiovascular Diseases | Emergencies | Critical Care | Music Therapy
-
University of Alabama at BirminghamCompleted
-
University of Texas at AustinRecruitingPathologic Processes | Nervous System Diseases | Immune System Diseases | Multiple Sclerosis | Demyelinating Autoimmune Diseases, CNS | Autoimmune Diseases of the Nervous System | Demyelinating Diseases | Autoimmune DiseasesUnited States
-
Geisinger ClinicCompletedAlzheimer Disease | Lewy Body Disease | Frontotemporal Dementia | Behavioral and Psychiatric Symptoms of DementiaUnited States
-
Icahn School of Medicine at Mount SinaiCompleted
-
Afyonkarahisar Health Sciences UniversityCompleted
-
KU LeuvenRecruitingPreoperative Anxiety | Preoperative CareBelgium
-
MS Ramaiah Medical College & HospitalsIndian Council of Medical ResearchCompletedStress | Stress, Psychological | Psychology, SocialIndia
-
University of HelsinkiKarolinska Institutet; University of Turku; Folkhälsan Research Center; University... and other collaboratorsNot yet recruitingLanguage Development Disorders | Language Development | Dyslexia, DevelopmentalFinland